HeartLogic monitoring in heart failure patients
Part of Heart & circulation clinical trials.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a heart defibrillator or pacemaker implanted within the last 6 months that supports HeartLogic monitoring
- You have a history of heart failure with reduced pumping strength (ejection fraction ≤40%) or past hospitalization for heart failure
- Your current heart failure symptoms are mild to moderate (NYHA Class II or III, meaning you feel short of breath with activity or minimal activity)
- You can receive wireless device check-ins at home and attend study visits
- You have valid health insurance coverage in France
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This study tests a small chest sensor that tracks your heart activity while you're in the hospital. It may help doctors better manage heart failure and prevent future crises.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
This trial tests if using HeartLogic, a feature in your heart device that tracks early warning signs, can help your care team manage your heart failure better and keep you out of the hospital. If you already have a compatible CRT-D or ICD and use remote monitoring, you may be able to join.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.